RecruitingPhase 1NCT06666270

Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors

Studying Malignant epithelial tumor of ovary

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
Intervention
SYN818(drug)
Enrollment
30 target
Eligibility
18 years · All sexes
Timeline
20242026

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06666270 on ClinicalTrials.gov

Other trials for Malignant epithelial tumor of ovary

Additional recruiting or active studies for the same condition.

See all trials for Malignant epithelial tumor of ovary

← Back to all trials